SpotitEarly

Dog
Oct 2, 2025

Hackensack Meridian, NJ startup target cancer with dog-powered diagnostic

SpotitEarly and the health care giant will launch the work with a 2,000-participant study focused on breast cancer.

SpotitEarly CEO Shlomi Madar speaks with NJBIZ Editor Jeff Kanige on May 21, 2025.
Jun 2, 2025

NJBIZ Conversations: SpotitEarly CEO Shlomi Madar

The chief executive officer describes the company's canine diagnostic technology and where it goes from here.